Apogee CMO exercises options and sells shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Apogee Therapeutics’ Chief Medical Officer Carl Dambkowski exercised stock options for 4,125 shares of common stock at $22.8600 per share on August 5, 2026, and on the same date sold 5,500 shares at $134.1700 per share under a Rule 10b5-1 trading plan. After the option exercise, 110,665 option shares from this award remained outstanding; the option originally covered 175,345 shares vesting in 48 equal monthly installments through December 18, 2027.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F2 | 4,125 | $0.00 | $0.00 |
| Exercise | Common Stock | 4,125 | $22.86 | $94K |
| Sale | Common Stock F1 | 5,500 | $134.17 | $738K |
Footnotes (2)
- F1. This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 22, 2025.
- F2. This option represents the right to purchase 175,345 shares of the Issuer's common stock, which will vest in forty-eight equal monthly installments through December 18, 2027, subject to the Reporting Person's continued service to the Issuer.
Key Figures
Key Terms
Rule 10b5-1 trading plan financial
Stock Option (Right to Buy) financial
vest in forty-eight equal monthly installments financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transactions did Apogee Therapeutics (APGE) report for its CMO?
At what prices did the Apogee Therapeutics (APGE) insider trades occur?
Was the Apogee Therapeutics (APGE) insider sale under a Rule 10b5-1 plan?
What is the vesting schedule for the Apogee Therapeutics (APGE) option grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.